InsidersTradesSigma
Track the Renalytix plc stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €576.9m. The latest transaction was reported on 13 February 2026 (Purchase). Among the most active insiders: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Renalytix plc is a company focused on developing diagnostic solutions for kidney diseases. It leverages advanced technologies to enhance the management of patients with chronic kidney conditions.